Fluconazole-, Amphotericin-B-, Caspofungin-, and Anidulafungin-Resistant Candida ciferrii: An Unknown Cause of Systemic Mycosis in a Child

被引:16
作者
Agin, Hasan [1 ]
Ayhan, Yuce [2 ]
Devrim, Ilker [1 ]
Gulfidan, Gamze [2 ]
Tulumoglu, Sener [2 ]
Kayserili, Ertan [1 ]
机构
[1] Dr Behcet Uz Child Dis & Pediat Surg Training & R, Dept Pediat, Izmir, Turkey
[2] Dr Behcet Uz Child Dis & Pediat Surg Training & R, Dept Infect Dis & Clin Microbiol, Izmir, Turkey
关键词
Candida ciferri; Candidemia; Amphotericin-B; Fluconazole; Caspofungin; Anidulafungin; Voriconazole; ANTIFUNGAL AGENTS; NATIONAL SURVEILLANCE; SPECIES DISTRIBUTION; CLINICAL-PRACTICE; SUSCEPTIBILITY; VORICONAZOLE; PROGRAM;
D O I
10.1007/s11046-011-9418-6
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Candida ciferrii, which is known as an agent of superficial yeast infection and onychomycosis, has rarely been isolated as an agent of candidemia. Limited reports have suggested different patterns of antifungal sensitivity. We report a rare candidemia case caused by c.ciferrii in an 8-year-old child in which isolated candida species were resistant to amphotericin-B (MIC > 1 mu g/ml), fluconazole, (MIC a parts per thousand yen 64 mu g/ml), caspofungin (MIC a parts per thousand yen 32 mu g/ml), and anidulafungin (MIC a parts per thousand yen 32 mu g/ml) but sensitive to voriconazole (MIC a parts per thousand currency sign 0.12 mu g/ml). As far as we aware, this was the first recorded C. ciferrii candidemia case in children.
引用
收藏
页码:237 / 239
页数:3
相关论文
共 15 条
[1]   Increasing incidence of candidemia:: Results from a 20-year nationwide study in Iceland [J].
Asmundsdóttir, LR ;
Erlendsdóttir, H ;
Gottfredsson, M .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (09) :3489-3492
[2]   Distribution and antifungal susceptibility of Candida species causing candidemia from 1996 to 1999 [J].
Cheng, MF ;
Yu, KW ;
Tang, RB ;
Fan, YH ;
Yang, YL ;
Hsieh, KS ;
Ho, M ;
Lo, HJ .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2004, 48 (01) :33-37
[3]   PREVALENCE OF CANDIDA-CIFERRII IN ELDERLY PATIENTS WITH TROPHIC DISORDERS OF THE LEGS [J].
DEGENTILE, L ;
BOUCHARA, JP ;
LECLECH, C ;
CIMON, B ;
SYMOENS, F ;
CHABASSE, D .
MYCOPATHOLOGIA, 1995, 131 (02) :99-102
[4]   In vitro susceptibility of Candida species to five antifungal agents in a German university hospital assessed by the reference broth microdilution method and Etest [J].
Fleck, Ralf ;
Dietz, Annebaerbel ;
Hof, Herbert .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 59 (04) :767-771
[5]   CANDIDA-CIFERRII AND CANDIDA-CHIROPTERORUM ISOLATED FROM CLINICAL SPECIMENS [J].
FURMAN, RM ;
AHEARN, DG .
JOURNAL OF CLINICAL MICROBIOLOGY, 1983, 18 (05) :1252-1255
[6]   Candida ciferrii, a new fluconazole-resistant yeast causing systemic mycosis in immunocompromised patients [J].
Gunsilius, E ;
Lass-Flörl, C ;
Kähler, CM ;
Gastl, G ;
Petzer, AL .
ANNALS OF HEMATOLOGY, 2001, 80 (03) :178-179
[7]  
Kreger-Van Rij N J, 1965, Mycopathol Mycol Appl, V26, P49, DOI 10.1007/BF02098589
[8]   Voriconazole activity against clinical yeast isolates: a multicentre Italian study [J].
Morace, G ;
Polonelli, L .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2005, 26 (03) :247-253
[9]   Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America [J].
Pappas, Peter G. ;
Kauffman, Carol A. ;
Andes, David ;
Benjamin, Daniel K., Jr. ;
Calandra, Thierry F. ;
Edwards, John E., Jr. ;
Filler, Scott G. ;
Fisher, John F. ;
Kullberg, Bart-Jan ;
Ostrosky-Zeichner, Luis ;
Reboli, Annette C. ;
Rex, John H. ;
Walsh, Thomas J. ;
Sobel, Jack D. .
CLINICAL INFECTIOUS DISEASES, 2009, 48 (05) :503-535
[10]   Resistance to echinocandin-class antifungal drugs [J].
Perlin, David S. .
DRUG RESISTANCE UPDATES, 2007, 10 (03) :121-130